Sutro Biopharma, Inc. engages in the drug discovery, development and manufacture of pharmaceutical products. It focuses on the next generation cancer and autoimmune therapeutics. The company was founded by James R. Swartz and Sutanto Widjaja on April 21, 2003 and is headquartered in South San Francisco, CA.
Fundamentals
Mkt Cap
$254.02M
Volume
-
52W High
$43.85
52W Low
$7.15
PE Ratio
-0.82
Avg. Volume
318,291.81
EPS (Annual)
-$22.49
P/B
-2.29
Rev/Employee
$748,058.39
Earnings
Aug 12
55
Bullish Sentiment
How do you feel about STRO?
Zaksab
$STRO worries about barriers to entry falling in the industry and particularly affecting traditional small biotechs who naturally lack scale?
Zaksab
$STRO rates rising hitting long duration assets, no material news till next year, drawdown makes sense imho